Home > PS Ratio > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
PS (Price/Sales) Ratio

The Current P/S Ratio of PROCTER & GAMBLE HEALTH is 6.75.

Share Price ₹5,220.3Feb 02,2026
Market Cap ₹8,665.6 Cr
Sales-TTM₹1,284.4 CrTTM-Standalone Results
Price/Sales6.75xCalculated as Market Cap/Sales
Explore Stock Analytics
AD     Remove this Ad
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of PROCTER & GAMBLE HEALTH

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of PROCTER & GAMBLE HEALTH is calculated as :

Current Market Cap [ ₹8,665.6 Cr] as on Feb 02,2026

(/) Sales [ ₹1,284.4 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 6.75x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '6.75 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of PROCTER & GAMBLE HEALTH !

The chart below summarizes the trend in P/S Ratio of PROCTER & GAMBLE HEALTH over the last five years.

Historical PS (Price/Sales) ratio chart of PROCTER & GAMBLE HEALTH


PS Ratio Performance Analysis for PROCTER & GAMBLE HEALTH

- PROCTER & GAMBLE HEALTH 's latest p/e ratio is 6.75x.

- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Mar2025 to Jun2022 averaged 7.31x.

- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 7.09x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Mar2025 at 9.14x.

- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2022 of 6.24x.


How does PROCTER & GAMBLE HEALTH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
PROCTER & GAMBLE HEALTH 1,284.46.758,665.6
SUN PHARMACEUTICAL INDUSTRIES LTD56,809.16.88390,828.0
DIVIS LABORATORIES LTD10,029.015.78158,227.0
CIPLA LTD28,351.13.74105,961.0
TORRENT PHARMACEUTICALS LTD12,248.011.03135,045.0
DR REDDYS LABORATORIES LTD34,682.22.8598,682.5
MANKIND PHARMA LTD13,576.96.2985,330.9
ZYDUS LIFESCIENCES LTD24,493.93.6188,473.1
LUPIN LTD24,750.73.9397,270.2
AUROBINDO PHARMA LTD32,514.52.1068,250.0
ABBOTT INDIA LTD6,714.48.6558,046.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PROCTER & GAMBLE HEALTH 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.10x
Max industry PS 15.78x
Median industry PS 6.29x
Average industry PS 6.51x



You may also like the below Video Courses